dalteparin has been researched along with Peritoneal Carcinomatosis in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pross, M | 2 |
| Lippert, H | 2 |
| Nestler, G | 2 |
| Kuhn, R | 1 |
| Langer, H | 2 |
| Mantke, R | 1 |
| Schulz, HU | 2 |
| Misselwitz, F | 1 |
| Krüger, S | 1 |
| Halangk, W | 1 |
2 other studies available for dalteparin and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Effect of low molecular weight heparin on intra-abdominal metastasis in a laparoscopic experimental study.
Topics: Abdominal Neoplasms; Adenocarcinoma; Animals; Anticoagulants; Disease Models, Animal; Dose-Response | 2004 |
Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy.
Topics: Abdominal Neoplasms; Adenocarcinoma; Animals; Anticoagulants; Cell Adhesion; Cell Line, Tumor; Hepar | 2003 |